Mayo Collaborative Services, Inc.

Mayo Collaborative Services, Inc., doing business as Mayo Clinic Laboratories, is a for-profit subsidiary of the nonprofit Mayo Clinic that delivers clinical laboratory testing and diagnostic services to federal agencies exclusively as a prime contractor, competing full-and-open with no set-aside designations. Based in Rochester, Minnesota, the vendor operates across NAICS 81402 (Medical Laboratories) and PSC 80 (Reference Laboratory Testing), with a federal footprint of 602 prime awards valued at $197.8 million in combined potential value across 36 distinct customer agencies.

The NIH Clinical Center dominates Mayo Collaborative Services' federal revenue base. The top five customers by potential value account for 91% of combined awards: the NIH Clinical Center leads with 40 awards worth $87.7 million, the NIH Office of the Chief Operating Officer contributes 63 awards worth $51.7 million, VA Veterans Integrated Service Network 23 (VISN 23) places 55 awards worth $23.4 million, the Defense Health Agency awards 24 contracts worth $13.2 million, and VISN 22 contributes 9 awards worth $4.1 million. The vendor's customer concentration reflects a strategic focus on federal health agencies and research institutions rather than broad-based DoD or civilian IT penetration; by award count, 462 of 602 awards fall under NAICS 81402 (Medical Laboratories), and 438 are coded to PSC Reference Laboratory Testing.

Mayo Collaborative Services holds seat on five active parent vehicles: a Blanket Purchase Agreement (BPA 269CL90005) generating 93 task orders from NIH and other agencies, an IDC with VA VISN 23 valued at $7.0 million extending through December 2030 with four active delivery orders, a $26.73 million single-award IDC with the NIH Clinical Center for reference laboratory testing (ultimate completion January 31, 2027) with nine executed task orders totaling approximately $23.7 million obligated, an IDC with VA VISN 17 (ceiling $775,000, extending through September 22, 2027) with multiple annual delivery orders for referral laboratory testing in Dallas, and a $250,000 single-award NIH Clinical Center IDC for specialized testing (ultimate completion July 31, 2026). Representative prime awards include a $5.96 million delivery order from the NIH Clinical Center (February 1, 2024, reference laboratory testing for laboratory medicine), a $2.715 million delivery order from the NIH Clinical Center (February 1, 2026, reference laboratory testing), and a $650,000 delivery order from VA VISN 23 (January 1, 2026, reference laboratory testing in Minneapolis).

Activity has remained stable at 11–14 awards annually over the past five years (2022–2026), with 14 awards completing within the next twenty-four months carrying combined potential value of $8.2 million — a moderate recompete exposure for this segment of the portfolio. Service Contract Inventory reporting shows SCI-reportable invoiced revenue of approximately $25 million across fiscal years 2022–2025, with FY2022 at $6.2 million (9.0 FTEs), FY2023 at $6.5 million (8.3 FTEs), FY2024 at $6.3 million (9.8 FTEs), and FY2025 at $6 million (13.3 FTEs). On federal services contracts captured in SCI, median government-paid rates run around $469.99/hr, with senior labor pricing through $1,849.51/hr and entry-level rates around $270.94/hr. Across SCI-reportable prime contracts, the vendor self-performs all reported hours with zero sub-engagement — Mayo Collaborative Services does not subcontract and operates as an integrated delivery organization for all federal laboratory services work.

Mayo Clinic Laboratories' competitive posture across its federal footprint is characterized by full-and-open competition with no reliance on small business set-asides. All identified awards carry firm fixed-price pricing and no set-aside designation, reflecting established technical capability and pricing competitiveness in federal laboratory testing markets. Performance locations span Rochester, Minnesota (primary lab operations); Bethesda, Maryland (NIH Clinical Center support); Dallas, Texas (VISN 17); Phoenix, Arizona (VISN 22); Minneapolis, Minnesota (VISN 23); and other VA facility locations nationwide. The vendor does not pursue subcontractor relationships or teaming arrangements — its federal business model is direct prime delivery leveraging Mayo Clinic's clinical laboratory infrastructure and expertise.